Clinical Trial Update: Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of Iparomlimab and Tuvonralimab with chemoradiation for locally recurrent and oligometastatic cervical cancer is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Cervical Cancer, Neoplasm Recurrence, Local | Phase 2 | Status: RECRUITING